Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort ascending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort ascending Date Posted
Legal Trainee – Research & Development and Innovative Medicines Basel (City) Switzerland Legal Innovative Medicines Others Oct 22, 2024
Legal Trainee - Novartis Operations Basel (City) Switzerland Operations CTS Others Oct 15, 2024
Digital Project Intern Rotkreuz (Office-Based) Switzerland International Innovative Medicines Others Oct 15, 2024
Embrace Advisor Verona Field Force (Italy) Italy International Innovative Medicines Others Oct 16, 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others Oct 22, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others May 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) France Innovative Medicines Others May 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others May 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Jun 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) France People & Organization Innovative Medicines Others Jul 04, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Aug 19, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
BPA Planning Process, RLT Baarle Nassau Netherlands Finance Innovative Medicines Audit & Finance Aug 05, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Sep 26, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Sep 27, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024
Global Finance Master Data Sr Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
Commercial BPA Manager Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Sep 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Oct 22, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turkey Finance Innovative Medicines Audit & Finance Oct 10, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Aug 20, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia